Pages that link to "Q41138649"
Jump to navigation
Jump to search
The following pages link to Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4. (Q41138649):
Displaying 18 items.
- CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy (Q28270773) (← links)
- Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases (Q30500527) (← links)
- The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation (Q33707690) (← links)
- CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity (Q33826028) (← links)
- Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19. (Q34224001) (← links)
- CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification (Q34242679) (← links)
- Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors (Q36365782) (← links)
- Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice (Q36597251) (← links)
- Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. (Q36654682) (← links)
- CD19 and CD32b differentially regulate human B cell responsiveness (Q37571579) (← links)
- Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy (Q40963463) (← links)
- Cocktails of ricin a‐chain immunotoxins against different antigens on hodgkin and sternberg‐reed cells have superior anti‐tumor effects against H‐RS cells in vitro and solid Hodgkin tumors in mice (Q41283633) (← links)
- The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity (Q41360894) (← links)
- Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms (Q41677546) (← links)
- CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation (Q43754794) (← links)
- Placental protein 14 regulates selective B cell responses (Q44491008) (← links)
- CD19 differentially regulates BCR signalling through the recruitment of PI3K. (Q45299837) (← links)
- Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation (Q64255784) (← links)